Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria

[1]  Johannes Bauer,et al.  Privacy Concerns in Responses to Sensitive Questions. A Survey Experiment on the Influence of Numeric Codes on Unit Nonresponse, Item Nonresponse, and Misreporting , 2016 .

[2]  C. Adebamowo,et al.  Qualitative study of barriers to cervical cancer screening among Nigerian women , 2016, BMJ Open.

[3]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[4]  M. Boulvain,et al.  Education efforts may contribute to wider acceptance of human papillomavirus self-sampling , 2015, International journal of women's health.

[5]  W. Quint,et al.  Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control , 2014, Journal of Clinical Microbiology.

[6]  C. Adebamowo,et al.  Age-specific prevalence of human papilloma virus infection among Nigerian women , 2014, BMC Public Health.

[7]  P. Bansil,et al.  Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach , 2014, BMC Public Health.

[8]  C. Adebamowo,et al.  HIV associated high-risk HPV infection among Nigerian women , 2013, BMC Infectious Diseases.

[9]  W. Blattner,et al.  Cervical cancer risk factors among HIV-infected Nigerian women , 2013, BMC Public Health.

[10]  R. Banzi,et al.  High‐risk HPV testing on self‐sampled versus clinician‐collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening , 2013, International journal of cancer.

[11]  A. Banjo,et al.  Prevalence of Human Papilloma Virus DNA in HIV Positive Women in Lagos University Teaching Hospital (LUTH) Lagos, Nigeria , 2013 .

[12]  S. Kjaer,et al.  Determinants of acceptance of cervical cancer screening in Dar es Salaam, Tanzania , 2012, BMC Public Health.

[13]  W. Blattner,et al.  Cancer incidence in Nigeria: a report from population-based cancer registries. , 2012, Cancer epidemiology.

[14]  W. Quint,et al.  Dry Storage and Transport of a Cervicovaginal Self-Sample by Use of the Evalyn Brush, Providing Reliable Human Papillomavirus Detection Combined with Comfort for Women , 2012, Journal of Clinical Microbiology.

[15]  Jennifer S. Smith,et al.  Knowledge and Acceptability of Pap Smears, Self-Sampling and HPV Vaccination among Adult Women in Kenya , 2012, PloS one.

[16]  S. Wacholder,et al.  The age‐specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen‐and‐treat strategies , 2012, International journal of cancer.

[17]  H. Boga,et al.  Factors Affecting Uptake of Cervical Cancer Early Detection Measures Among Women in Thika, Kenya , 2012, Health care for women international.

[18]  C. Maxia,et al.  Prevalence of human papillomavirus infection in women in Benin, West Africa , 2011, Virology Journal.

[19]  I. Onyiaorah,et al.  Knowledge, attitude and practice of cervical cancer screening among women attending gynecology clinics in a tertiary level medical care center in southeastern Nigeria. , 2011, The Journal of reproductive medicine.

[20]  Sylvia C. Mupepi,et al.  Knowledge, attitudes, and demographic factors influencing cervical cancer screening behavior of Zimbabwean women. , 2011, Journal of women's health.

[21]  L. Pritchett,et al.  Estimating Wealth Effects Without Expenditure Data—Or Tears: An Application To Educational Enrollments In States Of India* , 2001, Demography.

[22]  L. Bruni,et al.  Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. , 2010, The Journal of infectious diseases.

[23]  J. Zeichner,et al.  The role of the human papillomavirus (HPV) vaccine in developing countries , 2010, International journal of dermatology.

[24]  F. Denis,et al.  Dépistage et typage des infections à HPV par technique INNO-LiPA sur milieu liquide Easyfix Labonord après extraction QIAamp DNA Blood Mini Kit® Qiagen et Nuclisens easyMAG® Biomérieux , 2010 .

[25]  S. Hantz,et al.  [HPV detection and typing by INNO-LiPA assay on liquid cytology media Easyfix Labonord after extraction QIAamp DNA Blood Mini Kit Qiagen and Nuclisens easyMAG Biomérieux]. , 2010, Pathologie et biologie.

[26]  J. Waller,et al.  Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London , 2009, Journal of medical screening.

[27]  K. Lakshmaiah,et al.  HPV screening for cervical cancer in rural India. , 2009, The New England journal of medicine.

[28]  S. Franceschi,et al.  HPV infection in women with and without cervical cancer in Conakry, Guinea , 2009, British Journal of Cancer.

[29]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[30]  Joakim Dillner,et al.  Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. , 2008, Vaccine.

[31]  J. Salomon,et al.  Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination. , 2008, Journal of the National Cancer Institute.

[32]  R. Tourangeau,et al.  Sensitive questions in surveys. , 2007, Psychological bulletin.

[33]  Michael Quinn,et al.  Chapter 8: Screening for cervical cancer in developing countries. , 2006, Vaccine.

[34]  S. Franceschi,et al.  Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis , 2005, The Lancet.

[35]  L. Morison,et al.  Comparison of non-invasive sampling methods for detection of HPV in rural African women , 2005, Sexually Transmitted Infections.

[36]  Hua Yang,et al.  Detection of Human Immunodeficiency Virus Type 1 DNA in Dried Blood Spots by a Duplex Real-Time PCR Assay , 2005, Journal of Clinical Microbiology.

[37]  B. Lloveras,et al.  Human papillomavirus genotypes in rural Mozambique , 2001, The Lancet.

[38]  B. Achinstein,et al.  Journal of the National Cancer Institute, Vol. 29, 1962: Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance. , 2009, Nutrition reviews.